ARK Genomic Revolution ETF (BATS:ARKG) Shares Sold by Wells Fargo & Company MN

Wells Fargo & Company MN lowered its stake in ARK Genomic Revolution ETF (BATS:ARKG) by 73.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 346,396 shares of the company’s stock after selling 941,829 shares during the period. Wells Fargo & Company MN owned 0.61% of ARK Genomic Revolution ETF worth $8,156,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of ARKG. Hemington Wealth Management grew its position in ARK Genomic Revolution ETF by 44.6% during the fourth quarter. Hemington Wealth Management now owns 1,310 shares of the company’s stock valued at $30,000 after buying an additional 404 shares during the period. Wealthcare Advisory Partners LLC increased its stake in shares of ARK Genomic Revolution ETF by 2.8% in the 4th quarter. Wealthcare Advisory Partners LLC now owns 15,903 shares of the company’s stock worth $374,000 after acquiring an additional 435 shares during the last quarter. Avantax Advisory Services Inc. increased its holdings in shares of ARK Genomic Revolution ETF by 2.5% during the 4th quarter. Avantax Advisory Services Inc. now owns 28,701 shares of the company’s stock worth $676,000 after buying an additional 702 shares during the last quarter. Ping Capital Management Inc. increased its position in shares of ARK Genomic Revolution ETF by 7.1% during the 4th quarter. Ping Capital Management Inc. now owns 15,000 shares of the company’s stock worth $353,000 after purchasing an additional 1,000 shares during the last quarter. Finally, Crescent Grove Advisors LLC boosted its position in shares of ARK Genomic Revolution ETF by 5.5% during the 4th quarter. Crescent Grove Advisors LLC now owns 30,509 shares of the company’s stock worth $718,000 after purchasing an additional 1,595 shares during the period.

ARK Genomic Revolution ETF Trading Down 12.4 %

Shares of BATS:ARKG opened at $20.68 on Friday. The firm’s 50-day moving average is $23.22 and its two-hundred day moving average is $24.39. ARK Genomic Revolution ETF has a 1 year low of $17.51 and a 1 year high of $31.16.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.